Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison B Goldfine

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
The New England Journal of Medicine|September 12, 2008
Assessing the cardiovascular safety of diabetes therapiesAllison B Goldfine
Current Opinion in Cardiology|August 2, 2008
Modulating LDL cholesterol and glucose in patients with type 2 diabetes mellitus: targeting the bile acid pathwayAllison B Goldfine
Current Opinion in Endocrinology, Diabetes, and Obesity|March 5, 2008
The rough road for rosiglitazoneAllison B Goldfine
Current Opinion in Endocrinology, Diabetes, and Obesity|October 18, 2007
Changing horizons: approaches to diabetes care, current and futureAllison B Goldfine
The New England Journal of Medicine|April 27, 2012
Statins: is it really time to reassess benefits and risks?Allison B Goldfine
Current Opinion in Endocrinology, Diabetes, and Obesity|February 14, 2013
Metabolic surgery for type 2 diabetes: efficacy and risksFlorencia Halperin, Allison B Goldfine
Circulation|June 10, 2010
Management of diabetes mellitus in patients with cardiovascular disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trialAllison B Goldfine, Vivian Fonseca
Circulation|January 23, 2003
Cardiology patient pages. Cardiovascular disease in the diabetic patientAllison B Goldfine, Harvey L Goldfine
Obesity (Silver Spring, Md.)|May 27, 2016
How common is hypoglycemia after gastric bypass?Allison B Goldfine, Mary Elizabeth Patti
Gastroenterology|January 29, 2014
Hypoglycemia after gastric bypass: the dark side of GLP-1Mary-Elizabeth Patti, Allison B Goldfine
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
The New England Journal of Medicine|September 12, 2008
Assessing the cardiovascular safety of diabetes therapiesAllison B Goldfine
Current Opinion in Cardiology|August 2, 2008
Modulating LDL cholesterol and glucose in patients with type 2 diabetes mellitus: targeting the bile acid pathwayAllison B Goldfine
Current Opinion in Endocrinology, Diabetes, and Obesity|March 5, 2008
The rough road for rosiglitazoneAllison B Goldfine
Current Opinion in Endocrinology, Diabetes, and Obesity|October 18, 2007
Changing horizons: approaches to diabetes care, current and futureAllison B Goldfine
The New England Journal of Medicine|April 27, 2012
Statins: is it really time to reassess benefits and risks?Allison B Goldfine
Current Opinion in Endocrinology, Diabetes, and Obesity|February 14, 2013
Metabolic surgery for type 2 diabetes: efficacy and risksFlorencia Halperin, Allison B Goldfine
Circulation|June 10, 2010
Management of diabetes mellitus in patients with cardiovascular disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trialAllison B Goldfine, Vivian Fonseca
Circulation|January 23, 2003
Cardiology patient pages. Cardiovascular disease in the diabetic patientAllison B Goldfine, Harvey L Goldfine
Obesity (Silver Spring, Md.)|May 27, 2016
How common is hypoglycemia after gastric bypass?Allison B Goldfine, Mary Elizabeth Patti
Gastroenterology|January 29, 2014
Hypoglycemia after gastric bypass: the dark side of GLP-1Mary-Elizabeth Patti, Allison B Goldfine
Pageof 14